Immediate Impact
3 from Science/Nature 71 standout
Citing Papers
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
2024 Standout
Works of David H. Geller being referenced
Once-Weekly Exenatide in Youth With Type 2 Diabetes
2022
91-LB: Once-Weekly Exenatide in Youth with Type 2 Diabetes: A Pivotal Phase III Randomized Study
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David H. Geller | 608 | 600 | 282 | 366 | 37 | 1.5k | |
| Gary G. Gordon | 877 | 426 | 186 | 363 | 60 | 2.1k | |
| A.F. Clark | 800 | 432 | 202 | 224 | 79 | 1.6k | |
| L. M. Demers | 421 | 350 | 224 | 331 | 30 | 1.4k | |
| Philip Troen | 1138 | 603 | 327 | 992 | 87 | 2.2k | |
| A.C. Roy | 208 | 583 | 352 | 426 | 79 | 1.8k | |
| K Nahoul | 1145 | 465 | 245 | 607 | 66 | 2.0k | |
| T. Rabe | 427 | 289 | 536 | 603 | 128 | 1.8k | |
| Eckhard Leifke | 809 | 532 | 135 | 239 | 43 | 1.6k | |
| Leping Ye | 236 | 332 | 149 | 292 | 48 | 1.9k | |
| J.H.H. Thijssen | 799 | 379 | 171 | 245 | 85 | 2.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...